Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovoPedics is a pre-clinical stage medical device company specializing in regenerative medicine for orthopedic applications. The company is developing Meniscofix, a patented, bioresorbable fiber-reinforced scaffold designed to replace a severely damaged or missing meniscus. This technology aims to restore the natural biomechanics of the knee, thereby relieving pain and potentially preventing the progression of osteoarthritis. The scaffold is designed to be replaced by the patient's own tissue over time, providing a permanent biological solution. Founded as a spin-out from Rutgers University, NovoPedics is led by a team of orthopedic surgeons and biomedical engineers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovoPedics.